Phase I/Ib first-in-human study of HEK-NIZ985, a recombinant IL-15/IL-15Ra heterodimer, alone and in combination with spartalizumab, in adults with advanced and metastatic solid tumors
HEK-NIZ985;Spartalizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase I/Ib first-in-human study of HEK-NIZ985, a recombinant IL-15/IL-15Ra heterodimer, alone and in combination with spartalizumab, in adults with advanced and metastatic solid tumors ### Output: HEK-NIZ985;Spartalizumab